Meredith Buxton
Impact in
- Cancer Research top 1%
- Breast Cancer Treatment Studies
- Infectious Diseases top 2%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
Papers in
-
- Breast Cancer Treatment Studies 12
-
- COVID-19 Clinical Research Studies 10
- Co-authors
- Richard S. Garfein (1 shared paper)Peter R. Kerndt (1 shared paper)Lawrence J. Ouellet (1 shared paper)Don C. Des Jarlais (1 shared paper)Edward V. Morse (1 shared paper)David Vlahov (1 shared paper)Steffanie A. Strathdee (1 shared paper)Dan H. Moore (1 shared paper)
- Journals
- JAMA (7 papers)Journal of Clinical Oncology (4 papers)Breast Cancer Research and Treatment (3 papers)Clinical Cancer Research (3 papers)Neuro-Oncology (3 papers)
- Partner nations
- United StatesAustraliaNetherlands
In The Last Decade
Meredith Buxton
33 papers receiving 3.9k citations
Meredith Buxton's Hit Papers
Peers
Comparison fields: 5 of 76
- Cancer Research 879
- Infectious Diseases 932
- Statistics and Probability 219
- Oncology 368
- Radiology, Nuclear Medicine and Imaging 149
Countries citing papers authored by Meredith Buxton
This map shows the geographic impact of Meredith Buxton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meredith Buxton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meredith Buxton more than expected).
Fields of papers citing papers by Meredith Buxton
This network shows the impact of papers produced by Meredith Buxton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meredith Buxton. The network helps show where Meredith Buxton may publish in the future.
Co-authors
The 25 scholars most cited alongside Meredith Buxton, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 658 | |
| 2 | Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19 Hit paper breakdown → | 2021 | 518 |
| 3 | 2016 | 475 | |
| 4 | 2012 | 368 | |
| 5 | 2016 | 303 | |
| 6 | 2011 | 283 | |
| 7 | 2020 | 176 | |
| 8 | 2021 | 166 | |
| 9 | 2022 | 105 | |
| 10 | 2022 | 100 | |
| 11 | 2020 | 96 | |
| 12 | 2021 | 85 | |
| 13 | 2015 | 75 | |
| 14 | 2021 | 72 | |
| 15 | 2023 | 72 | |
| 16 | 2017 | 69 | |
| 17 | 2021 | 60 | |
| 18 | 2004 | 54 | |
| 19 | 2023 | 46 | |
| 20 | 2011 | 26 |
About Meredith Buxton
Meredith Buxton is a scholar working on Cancer Research, Infectious Diseases, Genetics, Statistics and Probability and Oncology, having authored 36 papers that have together received 4.0k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (12 papers), COVID-19 Clinical Research Studies (10 papers), Glioma Diagnosis and Treatment (4 papers), Statistical Methods in Clinical Trials (2 papers), PARP inhibition in cancer therapy (2 papers), HIV, Drug Use, Sexual Risk (1 paper), Venous Thromboembolism Diagnosis and Management (1 paper) and HER2/EGFR in Cancer Research (1 paper). The work is most often cited by research in Cancer Research (879 citations), Infectious Diseases (932 citations), Statistics and Probability (219 citations), Oncology (368 citations) and Radiology, Nuclear Medicine and Imaging (149 citations). Meredith Buxton has collaborated with scholars based in United States, Australia and Netherlands. Frequent co-authors include Richard S. Garfein, Peter R. Kerndt, Lawrence J. Ouellet, Don C. Des Jarlais, Edward V. Morse, David Vlahov, Steffanie A. Strathdee, Dan H. Moore, Olufunmilayo Ibironke Olopade and Lisa A. Carey. Their work appears in journals such as JAMA, Journal of Clinical Oncology, Breast Cancer Research and Treatment, Clinical Cancer Research and Neuro-Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.